Shire (SHP)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 3674.50p Today's change: -1.97%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 3674.50p 5 day change: -1.21%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 3674.50p 6 month change: -19.42%

Contact details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: www.shire.com

Company information

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Shire last night confirmed its $54bn (£32bn) deal with AbbVie was off, with a $1.635bn break fee owed.

21 October 2014
Shares
4

UK drugmaker Shire is eyeing up a number of acquisitions as it looks set to receive a windfall of as much as $1.6bn [...]

20 October 2014
Shares
6

Drug-maker Shire saw its share price tumble by a further 10 per cent yesterday, after US company AbbVie confirmed [...]

17 October 2014
Shares
1

The billion-pound deal between AbbVie and Shire could be over. [...]

16 October 2014
Shares
4

The fallout from US drug giant AbbVie’s decision late on Tuesday evening to reconsider its $54bn (£32bn) takeover [...]

16 October 2014
Shares
2

Shire shares fell almost 30 per cent in early trading this morning after its potential buyer AbbVie said it was [...]

15 October 2014
Shares
2

AbbVie is reconsidering its takeover of UK drugmaker Shire - and it could come at a hefty price. [...]

15 October 2014
Shares
10

After weeks of speculation, US pharmaceutical giant AbbVie has wrapped up the acquisition of Shire for £31bn [...]

18 July 2014
Shares
6

UK drug maker Shire relented to US rival AbbVie’s takeover attempts yesterday and accepted a sweetened £31.4bn [...]

15 July 2014
Shares
7

Shire's board has indicated that it is ready to recommend AbbVie's latest offer to buy the company for £31bn. [...]

14 July 2014
Shares
5

US drug giant AbbVie will embark on a final push to land UK rival Shire this week after meeting with representatives [...]

14 July 2014
Shares
12

US drug firm AbbVie’s bid to take over UK rival Shire softened again yesterday after shares fell for a second [...]

10 July 2014
Shares
5

US drugmarker AbbVie has retracted statements made by its chief executive claiming support for the company's bid [...]

9 July 2014
Shares
2

US drug firm AbbVie yesterday made a hotly anticipated fourth takeover bid for UK rival Shire, bumping up its [...]

9 July 2014
Shares
3

US-based pharmaceuticals company AbbVie has hiked its offer for Shire to £51.15 per share in the form of cash [...]

8 July 2014
Shares
5

Content tagged with "Shire"